Novavax stock was off 2.6%, to $204.30, amid a flat market. The shares soared to nearly $330 in Feb, when it had begun filing with US FDA.
For the three months ending 31 March 2021, the company’s total revenue reached $1.9bn, a surge compared to $8m during …
The US government has ordered 100 million doses and J&J says it can meet this commitment by June.
Because children have a lower risk of being badly affected by Covid-19 if they catch it.